STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study

A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.

CryptoAlerta — análise de criptomoedas e mercado em tempo real